Mapping the site on human IgG for binding of the MHC class I‐related receptor, FcRn

The analysis of the pharmacokinetics of wild‐type and mutated Fc fragments derived from human IgG1 indicates that Ile253, His310 and His435 play a central role in regulating serum half‐life in mice. Reduced serum half‐life of the recombinant, mutated fragments correlates with decreased binding to the MHC class I‐related neonatal Fc receptor, FcRn. In addition, the analysis of an Fc fragment in which His435 is mutated to Arg435 demonstrates that the sequence difference at this position between human IgG1 (His435) and IgG3 (Arg435) most likely accounts for the shorter serum half‐life of IgG3 relative to IgG1. In contrast to His310 and His435, the data indicate that His433 does not play a role in regulating the serum half‐life of human IgG1. Thus, the interaction site of mouse FcRn on human and mouse IgG1 involves the same conserved amino acids located at the CH2‐CH3 domain interface of the IgG molecule. The sequence similarities between mouse and human FcRn suggest that these studies have direct relevance to understanding the factors that govern the pharmacokinetics of therapeutic IgG.

[1]  Raimund J. Ober,et al.  Increasing the serum persistence of an IgG fragment by random mutagenesis , 1997, Nature Biotechnology.

[2]  C. Anderson,et al.  The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Jin‐Kyoo Kim,et al.  Abnormally short serum half‐lives of IgG in β2‐microglobulin‐deficient mice , 1996, European journal of immunology.

[4]  B. Ober,et al.  Expression and characterization of recombinant soluble peptide: I-A complexes associated with murine experimental autoimmune diseases. , 1998, Journal of immunology.

[5]  S. Morrison,et al.  Chimeric human-mouse IgG antibodies with shuffled constant region exons demonstrate that multiple domains contribute to in vivo half-life. , 1998, Cancer research.

[6]  R. Rodewald,et al.  Isolation and characterization of the Fc receptor from the fetal yolk sac of the rat , 1990, The Journal of cell biology.

[7]  J. S. Hunt,et al.  An IgG‐transporting Fc receptor expressed in the syncytiotrophoblast of human placenta , 1996, European journal of immunology.

[8]  H. Spiegelberg,et al.  Biological activities of immunoglobulins of different classes and subclasses. , 1974, Advances in immunology.

[9]  E. Ward,et al.  FcRn: the MHC class I-related receptor that is more than an IgG transporter. , 1997, Immunology today.

[10]  H. Broly,et al.  Use of hu-IgG-SCID mice to evaluate the in vivo stability of human monoclonal IgG antibodies. , 1994, Journal of immunological methods.

[11]  E. Ward,et al.  Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1. , 1997, Journal of immunology.

[12]  Jin‐Kyoo Kim,et al.  Localization of the site of the IgG molecule that regulates maternofetal transmission in mice , 1996, European journal of immunology.

[13]  A. Rees,et al.  Isolation and characterization of an Fc receptor from neonatal rat small intestine , 1985, European journal of immunology.

[14]  D. Schoenfeld,et al.  Increased clearance of IgG in mice that lack β2‐microglobulin: possible protective role of FcRn , 1996, Immunology.

[15]  J. M. Osborne,et al.  Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport. , 1996, Journal of immunology.

[16]  Esther Jacobowitz Israel,et al.  Requirement for a beta 2-microglobulin-associated Fc receptor for acquisition of maternal IgG by fetal and neonatal mice. , 1995, Journal of immunology.

[17]  E. Ward,et al.  Evidence that the hinge region plays a role in maintaining serum levels of the murine IgG1 molecule. , 1995, Molecular immunology.

[18]  B. Ober,et al.  The stoichiometry and affinity of the interaction of murine Fc fragments with the MHC class I-related receptor, FcRn. , 1996, Molecular immunology.

[19]  R. Shumaker.  PKCALC: a BASIC interactive computer program for statistical and pharmacokinetic analysis of data. , 1986, Drug metabolism reviews.

[20]  S. Morrison,et al.  The use of severe combined immunodeficiency mice to study the metabolism of human immunoglobulin g , 1994, Cancer.

[21]  E. Kabat,et al.  Sequences of proteins of immunological interest , 1991 .

[22]  S. Ho,et al.  Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. , 1989, Gene.

[23]  D. Lewis,et al.  Immunoglobulin G receptors of intestinal brush borders from neonatal rats. , 1983, Ciba Foundation symposium.

[24]  C. Story,et al.  A major histocompatibility complex class I-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus , 1994, The Journal of experimental medicine.

[25]  S L Morrison,et al.  Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants. , 1995, Biochemistry.

[26]  Jin‐Kyoo Kim,et al.  Localization of the site of the murine IgG1 molecule that is involved in binding to the murine intestinal Fc receptor , 1994, European journal of immunology.

[27]  Jin‐Kyoo Kim,et al.  Identifying amino acid residues that influence plasma clearance of murine IgG1 fragments by site‐directed mutagenesis , 1994, European journal of immunology.

[28]  T. Waldmann,et al.  Metabolic properties of IgG subclasses in man. , 1970, The Journal of clinical investigation.

[29]  R. Matre,et al.  Co‐localization of the neonatal Fcγ receptor and IgG in human placental term syncytiotrophoblasts , 1996 .

[30]  J. Deisenhofer.  Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. , 1981, Biochemistry.

[31]  S L Morrison,et al.  Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. , 1989, Journal of immunology.

[32]  J. D. Capra,et al.  High-level production of a functional immunoglobulin heterodimer in a baculovirus expression system. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Catabolism of human γG-immunoglobulins of different heavy chain subclasses: I. Catabolism of γG-myeloma proteins in man , 1968 .

[34]  P. Fraker,et al.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. , 1978, Biochemical and biophysical research communications.